Comparison between Indoco Remedies IPO and Pushp Brand (India) IPO.
Indoco Remedies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Pushp Brand (India) IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Indoco Remedies IPO is up to ₹73.50 Cr whereas the issue size of the Pushp Brand (India) IPO is up to ₹0.00 Cr. The final issue price of Indoco Remedies IPO is ₹245.00 per share and of Pushp Brand (India) IPO is .
| Indoco Remedies IPO | Pushp Brand (India) IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹220.00 per share | |
| Issue Price (Upper) | ₹245.00 per share | |
| Issue Price (Final) | ₹245.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 30,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹73.50 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 74,45,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 30,00,000 shares | 74,45,000 shares |
| Issue Size Total (Amount) | up to ₹73.50 Cr | up to ₹0.00 Cr |
Indoco Remedies IPO opens on Dec 17, 2004, while Pushp Brand (India) IPO opens on . The closing date of Indoco Remedies IPO and Pushp Brand (India) IPO is Dec 23, 2004, and , respectively.
Indoco Remedies IPO P/E ratio is 10.16, as compared to Pushp Brand (India) IPO P/E ratio of .
| Indoco Remedies IPO | Pushp Brand (India) IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)Pushp Brand (India) Ltd.'s revenue increased by 19% and profit after tax (PAT) rose by 29% between the financial year ending with March 31, 2026 and March 31, 2025.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.75 | 71.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹289.59 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹24.10 | ₹29.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.26% | 19.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Indoco Remedies IPO Retail Individual Investors (RII) are offered 7,50,000 shares while in Pushp Brand (India) IPO retail investors are offered 7,50,000 shares. Qualified Institutional Buyers (QIB) are offered 15,00,000 shares in Indoco Remedies IPO and 0 shares in Pushp Brand (India) IPO.
| Indoco Remedies IPO | Pushp Brand (India) IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 15,00,000 shares | 0 shares |
| NII | 7,50,000 shares | 0 shares |
| RII | 7,50,000 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 30,00,000 shares | 0 shares |
Indoco Remedies IPO subscribed in total, whereas Pushp Brand (India) IPO subscribed .
